NCT02123199View on ClinicalTrials.gov

Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Indacaterol (Onbrez®) /QAB149

Trial Locations (1)

Unknown

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY